<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">9305697</journal-id><journal-id journal-id-type="pubmed-jr-id">8786</journal-id><journal-id journal-id-type="nlm-ta">Osteoarthritis Cartilage</journal-id><journal-id journal-id-type="iso-abbrev">Osteoarthritis Cartilage</journal-id><journal-title-group><journal-title>Osteoarthritis and cartilage</journal-title></journal-title-group><issn pub-type="ppub">1063-4584</issn><issn pub-type="epub">1522-9653</issn></journal-meta><article-meta><article-id pub-id-type="pmid">39657871</article-id><article-id pub-id-type="pmc">12239852</article-id><article-id pub-id-type="doi">10.1016/j.joca.2024.12.001</article-id><article-id pub-id-type="manuscript">NIHMS2093210</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Acetabular dysplasia and the risk of developing hip osteoarthritis within 4&#x02013;8 years: An individual participant data meta-analysis of 18,807 hips from the World COACH consortium</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Riedstra</surname><given-names>Noortje S.</given-names></name><xref rid="A1" ref-type="aff">#</xref><xref rid="FN1" ref-type="author-notes">1</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Boel</surname><given-names>Fleur</given-names></name><xref rid="A1" ref-type="aff">#</xref><xref rid="FN1" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author"><name><surname>van Buuren</surname><given-names>Michiel M.A.</given-names></name><xref rid="A1" ref-type="aff">#</xref></contrib><contrib contrib-type="author"><name><surname>Ahedi</surname><given-names>Harbeer</given-names></name><xref rid="A2" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Arbabi</surname><given-names>Vahid</given-names></name><xref rid="A3" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Arden</surname><given-names>Nigel</given-names></name><xref rid="A4" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author"><name><surname>Baart</surname><given-names>Sara J.</given-names></name><xref rid="A1" ref-type="aff">#</xref></contrib><contrib contrib-type="author"><name><surname>Bierma-Zeinstra</surname><given-names>Sita M.A.</given-names></name><xref rid="A1" ref-type="aff">#</xref></contrib><contrib contrib-type="author"><name><surname>Cicuttini</surname><given-names>Flavia M.</given-names></name><xref rid="A5" ref-type="aff">&#x000b6;</xref></contrib><contrib contrib-type="author"><name><surname>Cootes</surname><given-names>Timothy F.</given-names></name><xref rid="A6" ref-type="aff">&#x02225;</xref></contrib><contrib contrib-type="author"><name><surname>Crossley</surname><given-names>Kay M.</given-names></name><xref rid="A7" ref-type="aff">##</xref></contrib><contrib contrib-type="author"><name><surname>Felson</surname><given-names>David T.</given-names></name><xref rid="A8" ref-type="aff">&#x02020;&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Giellis</surname><given-names>Willem Paul</given-names></name><xref rid="A9" ref-type="aff">&#x02021;&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Heerey</surname><given-names>Joshua</given-names></name><xref rid="A7" ref-type="aff">##</xref></contrib><contrib contrib-type="author"><name><surname>Jones</surname><given-names>Graeme</given-names></name><xref rid="A10" ref-type="aff">&#x000a7;&#x000a7;</xref></contrib><contrib contrib-type="author"><name><surname>Kluzek</surname><given-names>Stefan</given-names></name><xref rid="A11" ref-type="aff">&#x000b6;&#x000b6;</xref><xref rid="A12" ref-type="aff">&#x02225;&#x02225;</xref></contrib><contrib contrib-type="author"><name><surname>Lane</surname><given-names>Nancy E.</given-names></name><xref rid="A13" ref-type="aff">###</xref></contrib><contrib contrib-type="author"><name><surname>Lindner</surname><given-names>Claudia</given-names></name><xref rid="A6" ref-type="aff">&#x02225;</xref></contrib><contrib contrib-type="author"><name><surname>Lynch</surname><given-names>John A.</given-names></name><xref rid="A14" ref-type="aff">&#x02020;&#x02020;&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>van Meurs</surname><given-names>Joyce B.J.</given-names></name><xref rid="A1" ref-type="aff">#</xref></contrib><contrib contrib-type="author"><name><surname>Mosler</surname><given-names>Andrea</given-names></name><xref rid="A7" ref-type="aff">##</xref></contrib><contrib contrib-type="author"><name><surname>Nelson</surname><given-names>Amanda E.</given-names></name><xref rid="A15" ref-type="aff">&#x02021;&#x02021;&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Nevitt</surname><given-names>Michael C.</given-names></name><xref rid="A14" ref-type="aff">&#x02020;&#x02020;&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Oei</surname><given-names>Edwin H.</given-names></name><xref rid="A1" ref-type="aff">#</xref></contrib><contrib contrib-type="author"><name><surname>Runhaar</surname><given-names>Jos</given-names></name><xref rid="A1" ref-type="aff">#</xref></contrib><contrib contrib-type="author"><name><surname>Tang</surname><given-names>Jinchi</given-names></name><xref rid="A1" ref-type="aff">#</xref></contrib><contrib contrib-type="author"><name><surname>Weinans</surname><given-names>Harrie</given-names></name><xref rid="A16" ref-type="aff">&#x000a7;&#x000a7;&#x000a7;</xref></contrib><contrib contrib-type="author"><name><surname>Agricola</surname><given-names>Rintje</given-names></name><xref rid="A1" ref-type="aff">#</xref></contrib></contrib-group><aff id="A1"><label>#</label>Erasmus Medical Center, the Netherlands</aff><aff id="A2"><label>&#x02020;</label>University of Tasmania, Sydney Orthopaedic Research Institute, Australia</aff><aff id="A3"><label>&#x02021;</label>University Medical Center Utrecht, Orthopaedic-Biomechanics Research Group, the Netherlands</aff><aff id="A4"><label>&#x000a7;</label>University of Oxford, UK</aff><aff id="A5"><label>&#x000b6;</label>Monash University, Australia</aff><aff id="A6"><label>&#x02225;</label>University of Manchester, UK</aff><aff id="A7"><label>##</label>La Trobe University, Australia</aff><aff id="A8"><label>&#x02020;&#x02020;</label>Boston University School of Medicine, USA</aff><aff id="A9"><label>&#x02021;&#x02021;</label>University Medical Center Utrecht, the Netherlands</aff><aff id="A10"><label>&#x000a7;&#x000a7;</label>Menzies Institute for Medical Research, Australia</aff><aff id="A11"><label>&#x000b6;&#x000b6;</label>University of Oxford, UK</aff><aff id="A12"><label>&#x02225;&#x02225;</label>University of Nottingham, UK</aff><aff id="A13"><label>###</label>University of California at Davis, United States</aff><aff id="A14"><label>&#x02020;&#x02020;&#x02020;</label>University of California, United States</aff><aff id="A15"><label>&#x02021;&#x02021;&#x02021;</label>University of North Carolina at Chapel Hill, United States</aff><aff id="A16"><label>&#x000a7;&#x000a7;&#x000a7;</label>University Medical Center Utrecht, Delft University of Technology, the Netherlands</aff><author-notes><fn fn-type="other" id="FN1"><label>1</label><p id="P1">Shared first authorship.</p></fn><fn fn-type="con" id="FN2"><p id="P2">Author contributions</p><p id="P3">NSR, FB and RA initiated the study. NSR, FB and RA worked on the conceptual design of the study. MMAvB and RA identified eligible cohorts and contacted cohort investigators for collaboration. MMAvB, RA, NSR, FB, HA, AM, KC, JH, SK, JAL, JVM, ABM, AEN, MN, JT and HW collected the existing cohort data. MMAvB, NSR, FB, JT and RA have worked on the database and on the harmonization process. NSR, FB, and RA have worked on statistical analyses. NSR and FB wrote the manuscript under supervision of RA. All authors critically reviewed and revised the manuscript and contributed to interpretation of the data. All authors read and approved the final version of the manuscript. NR acts as guarantor and accepts full responsibility for the finished work and/or the conduct of the study, had access to the data, and controlled the decision to publish.</p></fn><corresp id="CR1"><label>*</label>Corresponding author. <email>n.s.riedstra@erasmusmc.nl</email> (N.S. Riedstra).</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>27</day><month>6</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>08</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>3</month><year>2026</year></pub-date><volume>33</volume><issue>3</issue><fpage>373</fpage><lpage>382</lpage><permissions><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract id="ABS1"><title>SUMMARY</title><sec id="S1"><title>Objective:</title><p id="P4">To study the association between various radiographic definitions of acetabular dysplasia (AD) and incident radiographic hip osteoarthritis (RHOA), and to analyze in subgroups.</p></sec><sec id="S2"><title>Methods:</title><p id="P5">Hips free of RHOA at baseline and with follow-up within 4&#x02013;8 years were drawn from the World COACH consortium. The Wiberg center edge angle (WCEA), acetabular depth width ratio (ADR), and the modified acetabular index (mAI) were calculated. AD was defined as WCEA&#x02264;25&#x000b0;, and for secondary analyses as WCEA&#x02264;20&#x000b0;, ADR &#x02264;250, mAI &#x02265; 13&#x000b0;, and a combination. A logistic regression model with generalized mixed effects with 3 levels adjusted for age, biological sex, and body mass index (BMI) was used. Descriptive statistics stratified by age, biological sex and BMI were reported.</p></sec><sec id="S3"><title>Results:</title><p id="P6">A total of 18,807 hips from 9 studies were included. Baseline characteristics: age 61.84 (&#x000b1; 8.32) years, BMI 27.40 (&#x000b1; 4.49) kg/m<sup>2</sup>, 70.1% women. 4766 hips (25.3%) had WCEA&#x02264;25&#x000b0;. Within 4&#x02013;8 years (mean 5.8 &#x000b1; 1.6) follow-up, 378 hips (2.0%) developed incident RHOA. We found an association between AD and RHOA (adjusted OR [aOR] 1.80 95% confidence interval [CI] 1.40&#x02013;2.34). In secondary analyses, all other definitions of AD were also associated with incident RHOA (aOR ranging from 1.52 95% CI 1.19&#x02013;1.94 to 1.96 95% CI 1.26&#x02013;3.02). Descriptive statistics showed that the relative risk (RR) in AD hips to develop RHOA was higher compared to non-AD hips in age group 61&#x02013;70 (RR 1.70), BMI &#x0003c; 25 (RR 1.66), and in female hips (RR 1.73).</p></sec><sec id="S4"><title>Conclusion:</title><p id="P7">AD was consistently associated with incident RHOA. Explorative analyses show that AD hips in women and age group 61&#x02013;70 years seem to be more at risk of developing RHOA compared to non-AD hips.</p></sec></abstract><kwd-group><kwd>Hip imaging</kwd><kwd>Risk factor</kwd><kwd>Developmental dysplasia</kwd><kwd>Harmonized</kwd><kwd>Epidemiology</kwd></kwd-group></article-meta></front><body><sec id="S5"><title>Introduction</title><p id="P8">There is no curative nonsurgical treatment available for hip osteoarthritis (OA).<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup> Therefore, prevention is critical, but there is a lack of knowledge on risk factors for the development of radiographic hip OA (RHOA). Identifying risk factors for this disease should be prioritized.</p><p id="P9">Subtle features of hip shape may predate the development of OA by many years and might therefore be a preventative target.<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup> Acetabular dysplasia (AD) has previously been identified as a risk factor for developing RHOA.<sup><xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R6" ref-type="bibr">6</xref></sup> AD is defined by insufficient coverage of the femoral head by the acetabulum.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> Concentrated focal stress on a relatively small area of the acetabulum<sup><xref rid="R7" ref-type="bibr">7</xref></sup> is thought to lead to early mechanical failure of the cartilage, and to eventually cause hip OA.<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R8" ref-type="bibr">8</xref>&#x02013;<xref rid="R10" ref-type="bibr">10</xref></sup></p><p id="P10">A systematic review on hip morphology and OA found an association between AD and RHOA odds ratio [OR] 2.38, 95% confidence interval [CI]: 1.84 to 3.07).<sup><xref rid="R9" ref-type="bibr">9</xref></sup> However, when analyzing individual studies, these have yielded conflicting results and highlight the need for robust analysis, avoiding inconsistencies in measurements and definitions.<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R11" ref-type="bibr">11</xref>&#x02013;<xref rid="R13" ref-type="bibr">13</xref></sup> Single cohorts are likely to be underpowered to determine whether specific high-risk subgroups are responsible for the associations found.<sup><xref rid="R9" ref-type="bibr">9</xref></sup> Likely due to the overall low number of included individuals and therefore decreased statistical power, existing prospective cohort studies include hips free of RHOA as well as those with doubtful RHOA at baseline, which may bias the presently known associations. Hips with doubtful RHOA already show mild radiographic changes (possible joint space narrowing [JSN] and signs of osteophytes), which may influence the radiographic measures of AD and represent the first signs of potential osteoarthritic changes.<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R13" ref-type="bibr">13</xref></sup></p><p id="P11">Using an individual participant data (IPD) meta-analysis, we aimed to investigate the association between AD, defined by the Wiberg center edge angle (WCEA) &#x02264;25&#x000b0; at baseline, and developing incident RHOA within 4&#x02013;8 years follow-up. For secondary analyses, we investigated whether other measures of AD and other threshold values to quantify AD were associated with incident RHOA. Finally, we performed subgroup analyses stratified by age, biological sex, and body mass index (BMI) to assess potential high-risk subgroups.</p></sec><sec id="S6"><title>Methods</title><sec id="S7"><title>Study design and participants</title><p id="P12">Participants were drawn from the Worldwide Collaboration on OsteoArthritis prediCtion for the Hip (World COACH) consortium. The World COACH consortium is an international collaboration of all worldwide available prospective cohort studies with sequential pelvic or hip imaging. The consortium profile has previously been published in detail elsewhere.<sup><xref rid="R14" ref-type="bibr">14</xref></sup></p><p id="P13">For the present study, we included all cohorts with a follow-up anteroposterior (AP) pelvic radiograph within 4&#x02013;8 years of a baseline radiograph, that also had an RHOA score available. This led to the inclusion of 9 cohorts (Cohort Hip and Cohort Knee [CHECK], Multi-center Osteoarthritis Study [MOST], Osteo Arthritis Initiative [OAI], Rotterdam Study-I [RS-I], Rotterdam Study-II [RS-II], Rotterdam Study-III [RS-III], the Chingford Study, The Johnston County Project [JoCo] and the Study of Osteoporotic Fractures [SOF]), and exclusion of two cohorts (Tasmanian Older Adults Cohort [TASOAC] and Femoroacetabular impingement and hip osteoarthritis cohort [FORCe]).</p><p id="P14">We included hips with known BMI, biological sex, and age at baseline. Next, we excluded hips without an original baseline RHOA score. We then excluded radiographs of insufficient quality for automated AD measurement calculation and all AP hip radiographs as they did not allow for constructing a horizontal reference line to adjust for pelvic rotation. Next, we included only the hips with an original RHOA score at follow-up and excluded all baseline hips with pincer morphology (acetabular overcoverage) as determined by a lateral center edge angle (LCEA) &#x02265;40&#x000b0;. We chose to do the latter to compare hips with AD to a reference group with normal acetabular coverage, and because studies have found an association between pincer morphology and RHOA or total hip replacement (THR).<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup> Finally, we included only hips free of any signs of RHOA at baseline (any score=0). Studying a population completely free of RHOA at baseline allows for the determination of true predictors of RHOA, as existing osteophytes may affect the measurement of AD and bias the association between AD and incident RHOA. Furthermore, excluding hips with doubtful RHOA isolates the effect of AD on incidence RHOA rather than the effect of AD on progression in hips that likely already have some form of RHOA. This led to a total inclusion of 18,807 hips.</p></sec><sec id="S8"><title>Radiographs</title><p id="P15">AP pelvic radiographs were taken at baseline and at follow-up between 4&#x02013;8 years in each included cohort, according to cohort-specific protocols which have been published previously<sup><xref rid="R15" ref-type="bibr">15</xref>&#x02013;<xref rid="R19" ref-type="bibr">19</xref></sup> (<xref rid="SD1" ref-type="supplementary-material">Supplementary material 1</xref>). To study the impact of the full-limb films from the MOST cohort on the associations between AD and RHOA, that are otherwise studied on pelvic radiographs, sensitivity analyses were performed excluding hips from the MOST cohort from the primary analysis.</p></sec><sec id="S9"><title>Radiographic measurements</title><p id="P16">To avoid measurement variability across cohorts, for the present study all AD measurements were calculated uniformly on baseline radiographs. The bony outline of the proximal femur and acetabulum were automatically annotated on the AP pelvic radiographs with a point set using the BoneFinder<sup>&#x000ae;</sup> software (<ext-link xlink:href="http://www.bone-finder/" ext-link-type="uri">www.bone-finder</ext-link>. com; The University of Manchester, UK).<sup><xref rid="R20" ref-type="bibr">20</xref></sup> This point set was used to perform automated radiographic measurements using a previously published Python script, which was adapted and validated for World COACH data, for which a detailed description can be found elsewhere.<sup><xref rid="R21" ref-type="bibr">21</xref>,<xref rid="R22" ref-type="bibr">22</xref></sup> The average of two trained reader&#x02019;s manual measurements were compared to automated morphological measurements. The average of the trained manual readers was considered the gold standard to which the automated method is compared. Intermethod interclass correlation coefficients (ICCs) range from 0.80 (0.60 &#x02013; 0.90) for the acetabular depth width ratio (ADR) to 0.88 (0.70 &#x02013; 0.95) for the WCEA.<sup><xref rid="R23" ref-type="bibr">23</xref></sup></p><p id="P17">Radiographic measurements to define AD are depicted (<xref rid="F1" ref-type="fig">Fig. 1</xref>). The amount of weight-bearing coverage of the femoral head by the acetabulum is measured by the WCEA<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R24" ref-type="bibr">24</xref></sup>. AD was defined as a WCEA &#x02264; 25&#x000b0; in the primary analysis and in subgroup analyses, and additionally by WCEA&#x02264;20&#x000b0; for secondary analyses.<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R12" ref-type="bibr">12</xref></sup> The ADR is a measure of depth of the acetabulum. AD was defined as an ADR &#x02264; 250 for secondary analyses.<sup><xref rid="R25" ref-type="bibr">25</xref></sup> The modified acetabular index (mAI) measures the inclination of the acetabular roof. AD was defined as an mAI &#x02265; 13&#x000b0; for secondary analyses.<sup><xref rid="R25" ref-type="bibr">25</xref></sup> In secondary analyses, the radiographic definitions of AD were studied individually and combined.</p></sec><sec id="S10"><title>Radiographic Hip Osteoarthritis Grading</title><p id="P18">At baseline and follow-ups, all included radiographs had scores available by either the Kellgren and Lawrence (KL) classification (CHECK, Chingford, JoCo, MOST, RS-I, RS-II, RS-III),<sup><xref rid="R26" ref-type="bibr">26</xref></sup> the modified Croft classification (SOF),<sup><xref rid="R27" ref-type="bibr">27</xref></sup> or a modified OA score (OAI).<sup><xref rid="R28" ref-type="bibr">28</xref></sup></p><p id="P19">The KL grading system defines OA severity in five grades(0&#x02212;4) using a combination of osteophyte, JSN severity, sclerosis and bone deformity.<sup><xref rid="R26" ref-type="bibr">26</xref></sup> The modified Croft grading system defines OA severity in five grades(0&#x02212;4) and is based on 5 radiographic features: JSN, osteophytes, subchondral sclerosis, cyst formation, and deformity.<sup><xref rid="R29" ref-type="bibr">29</xref></sup> The modified OA grades are based on the modified Croft grades and defines OA in 3 grades(0&#x02212;2), where 0 marks hips free of RHOA, 1 defines doubtful RHOA and 2 is definite RHOA.<sup><xref rid="R28" ref-type="bibr">28</xref></sup></p><p id="P20">Original OA scores per cohort were defined as &#x0201c;free of RHOA&#x0201d; (any score 0), &#x0201c;doubtful RHOA&#x0201d; (any score 1), or &#x0201c;definite RHOA&#x0201d; (KL &#x02265;2, Modified Croft &#x02265;2, Modified OA=2, or THR).<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R31" ref-type="bibr">31</xref></sup></p></sec><sec id="S11"><title>Outcome measurements</title><p id="P21">The outcome was incident score &#x0201c;definite RHOA&#x0201d; within 4&#x02013;8 years follow-up. Additionally for secondary analyses RHOA was defined as an ordinal outcome &#x0201c;free of RHOA&#x0201d;, &#x0201c;doubtful RHOA&#x0201d; and &#x0201c;definite RHOA&#x0201d;.</p></sec><sec id="S12"><title>Statistical analysis</title><p id="P22">All statistical analyses were performed in R version 4.1.1. Univariate differences in baseline characteristics between complete included and excluded cases were inspected. This means that we compared the included hips to the hips that were excluded because of OA score of 1 or 2 at baseline (<xref rid="F2" ref-type="fig">Fig. 2</xref>). The associations between baseline AD, defined by the WCEA&#x02264; 25&#x000b0;, and incident RHOA were estimated with mixed effects logistic regression models. Mixed effects were added to account for the potential clustering in the data within cohorts and participants. Random intercepts were determined on both participant and cohort level, with participants nested within the cohorts. The cohort was added as a level in this multi-level model to adjust for possible residual confounding by study differences. An example is the difference between an open population cohort (Chingford, JoCo, RS-I, RS-II, RS-III), and closed population cohort (CHECK, OAI, MOST, SOF). The results are expressed as adjusted OR (aOR) and unadjusted OR with 95% CI and were adjusted for baseline age, sex, and BMI. Additionally, a mixed model for ordinal data, namely RHOA classified as &#x0201c;free of RHOA&#x0201d;, &#x0201c;doubtful RHOA&#x0201d;, and &#x0201c;definite RHOA&#x0201d; was created using a forward build continuation ratio model to assess the impact of doubtful RHOA. Random effects were added to adjust for clustering, and the model was adjusted for baseline age, sex, and BMI. The ordinality assumption of the continuous ratio model was relaxed for AD, allowing the effect of AD to be different for each level of the outcome RHOA at follow-up. The results were presented as an effect plot of the marginal probabilities marginalized over the random effects for women, with mean baseline age and BMI and randomly selected left hip side. Secondary analyses were performed using the same model and 5 definitions of AD: 1) WCEA &#x02264; 20&#x000b0;, 2) ADR &#x02264; 250, 3) mAI &#x02265; 13&#x000b0;, 4) three combined measures (WCEA &#x02264; 25&#x000b0; and ADR &#x02264; 250 and mAI &#x02265; 13&#x000b0;), and 5) a pooled definition of any of the three measures (WCEA &#x02264; 25&#x000b0; or ADR &#x02264; 250 or mAI &#x02265; 13&#x000b0;). In the secondary analysis, when using a WCEA&#x02264;20&#x000b0; as the predictor, hips with a WCEA &#x0003e; 20&#x000b0; and WCEA&#x02264;25&#x000b0; were excluded from the reference group to compare AD hips to a clean population of hips completely free of AD. In the secondary analysis, when using any of the three measures for AD, the reference group contained hips free of AD and hips with only one or two measures of AD. We used descriptive statistics to explore whether specific subgroups may be more at risk to develop RHOA. Because of limited outcomes, it was not possible to perform subgroup analyses using logistic regression. We reported absolute risk (AR) and relative risk (RR) in AD and non-AD hips of developing RHOA stratified by age groups 40&#x02013;50, 51&#x02013;60, 61&#x02013;70 and &#x0003e; 70 years of age, by BMI by studying groups with a BMI &#x0003e; 25 and BMI&#x02264;25, and by biological sex. The following packages in R were used: Logistic regression was performed using the lme4-package.<sup><xref rid="R32" ref-type="bibr">32</xref></sup> The continuation ratio model was created using the GLMMadaptive package.<sup><xref rid="R33" ref-type="bibr">33</xref></sup> The effect plot was created using the ggplot2-package.<sup><xref rid="R34" ref-type="bibr">34</xref></sup></p></sec></sec><sec id="S13"><title>Results</title><sec id="S14"><title>Participants</title><p id="P23">The flow of hips from those available in World COACH to the current final study population is depicted (<xref rid="F2" ref-type="fig">Fig. 2</xref>). 18,807 hips free of any signs of RHOA at baseline were included. The mean interval between the baseline and follow-up radiograph across all cohorts was 5.8 &#x000b1; 1.6 years. Baseline demographic data stratified per cohort are presented in <xref rid="T1" ref-type="table">Table I</xref>. Our study population was younger than the excluded hips (61.84 &#x000b1; 8.32 versus 64.56 &#x000b1; 8.49 years, respectively); all other baseline characteristics and predictors were similar across included and excluded hips.</p></sec><sec id="S15"><title>Acetabular dysplasia</title><p id="P24">At baseline, 4766 (25.3%) hips had AD defined by a WCEA &#x02264;25&#x000b0;. 1164 (6.2%).</p><p id="P25">according to a WCEA &#x02264;20&#x000b0;, 5917 (31.5%) hips had an ADR &#x02264;250 and 397 (2.1%) hips had an mAI &#x02265; 13&#x000b0;. The overlap between measures is illustrated in <xref rid="SD2" ref-type="supplementary-material">supplementary material 2</xref>.</p></sec><sec id="S16"><title>Incident radiographic hip osteoarthritis</title><p id="P26">378 hips (2.0%) developed incident RHOA within 4&#x02013;8 years follow-up. The incidence of RHOA at follow-up per cohort were: CHECK: 13.4% Chingford: 8.4%, JoCo: 6.4%, MOST 0.6%, OAI: 0.5%, SOF: 1.7%, RS-I: 0.9%, RS-II: 0.4%, RS-III: 2.2%.</p></sec><sec id="S17"><title>Primary analysis: association between acetabular dysplasia and radiographic hip osteoarthritis</title><p id="P27">A significant association (aOR 1.80 (95% CI 1.40&#x02013;2.34) between AD (WCEA &#x02264;25&#x000b0;) and incident RHOA within 4&#x02013;8 years was observed. The association remained statistically significant after adjustment for covariates.</p><p id="P28">The effect plot of the marginal probabilities from the mixed model for ordinal data is shown in <xref rid="F3" ref-type="fig">Fig. 3</xref>. All marginal probabilities were calculated for hips free of RHOA, in women aged 62 years with a BMI of 27.4 kg/m<sup>2</sup> at baseline. The marginal probability for hips with AD to develop doubtful RHOA within 4&#x02013;8 years is 0.15 (95% CI 0.10&#x02013;0.20), compared to 0.17 (95% CI 0.11&#x02013;0.23) for hips free of AD. The marginal probability for AD hips to develop definite RHOA within 4&#x02013;8 years is 0.03 (95% CI 0.01&#x02013;0.08), compared to 0.02 (95% CI 0.01&#x02013;0.06) for AD-free hips.</p></sec><sec id="S18"><title>Sensitivity analysis excluding MOST</title><p id="P29">The study population excluding MOST resulted in a total of 17,031 hips. A significant association was found (aOR 1.89 95%CI 1.45 &#x02212;2.47) between hips with AD (WCEA &#x02264;25&#x000b0;) and incident RHOA in the study population excluding hips from the MOST cohort.</p></sec><sec id="S19"><title>Secondary analyses: association between various measures of acetabular dysplasia and radiographic hip osteoarthritis</title><p id="P30">Significant associations between AD defined by WCEA &#x02264;20&#x000b0;, ADR&#x02264;250 or either WCEA &#x02264;25&#x000b0; or ADR &#x02264;250 or mAI &#x02265; 13&#x000b0;) and incident RHOA within 4&#x02013;8 years were observed. The associations remained statistically significant after adjusting for covariates. Because of a limited number of events (14 hips), it was not possible to calculate the association in the AD defined by mAI&#x02265; 13&#x000b0; group. All ORs are summarized in <xref rid="T2" ref-type="table">Table II</xref>.</p></sec><sec id="S20"><title>Subgroup analyses</title><p id="P31">Descriptive statistics stratified by age group, biological sex, and BMI are summarized in <xref rid="T3" ref-type="table">Table III</xref>. The RR for hips with AD to develop RHOA was highest in age group 61&#x02013;70, in hips with BMI &#x0003c; 25, and in women.</p></sec></sec><sec id="S21"><title>Discussion</title><p id="P32">This IPD meta-analysis on the association between AD and incident RHOA in a large prospective study of 18,807 hips free of any RHOA at baseline, demonstrated a significant association between AD defined by a WCEA &#x02264;25&#x000b0; and incident RHOA within 4&#x02013;8 years. Additionally, hips with AD were more likely to progress from being RHOA-free to definite RHOA rather than doubtful RHOA compared to non-AD hips. Secondary analyses showed that other measures of AD (WCEA &#x02264;20&#x000b0;, ADR &#x02264;250 and a combination of WCEA&#x02264;25&#x000b0; and ADR &#x02264;250) were also associated with an increased risk of developing RHOA. Descriptive statistics show that AD hips in women, individuals aged 61&#x02013;70 and individuals with BMI &#x0003c; 25 have a higher RR to develop RHOA.</p><p id="P33">Several studies have shown that AD is associated with the development of RHOA. The strength of associations in prospective cohort studies ranged from aOR 1.56 (95% CI 1.09&#x02013;2.24) to aOR 5.45 (95% CI 2.40&#x02013;12.34).<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R35" ref-type="bibr">35</xref>,<xref rid="R36" ref-type="bibr">36</xref></sup> Conversely, a number of studies (case-control, prospective and cross-sectional) have failed to find such an association.<sup><xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R37" ref-type="bibr">37</xref>,<xref rid="R38" ref-type="bibr">38</xref></sup> Our results support the finding that AD is associated with RHOA, although the association in the present study is not as strong as previously reported. This may be explained by the fact that the present study population only included hips free of any RHOA at baseline, whereas previous prospective cohort studies also included hips with doubtful RHOA at baseline, in which the stronger associations may reflect an association between AD and progression of RHOA, rather than incident RHOA.<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R35" ref-type="bibr">35</xref>,<xref rid="R36" ref-type="bibr">36</xref></sup> Furthermore, publication bias may have played a role in selective publication of (strong) associations between AD and RHOA previously, and negative results may have been disfavored.<sup><xref rid="R39" ref-type="bibr">39</xref></sup> Time to follow-up as well as how AD and RHOA are measured and defined may also have contributed to variable strengths of associations in prospective studies or absence of an association in cross-sectional studies.</p><p id="P34">Although generalizable evidence is lacking, it has been hypothesized that AD leads to RHOA only in younger individuals.<sup><xref rid="R11" ref-type="bibr">11</xref></sup> Saberi et al. studied hips from RS-I and RS-II with an average age of 65 years at baseline and found that the magnitude of the association AD and RHOA was stronger in persons aged &#x02264;65 years at baseline (OR 2.59 95% CI 1.62&#x02013;4.16) compared to those aged &#x0003e; 65 years (OR 1.74 95% CI 0.90&#x02013;3.37). On average, the population in this IPD meta-analysis is younger (61.84 years), which is likely because only hips completely free of RHOA were included at baseline, whereas the aforementioned study also included hips with doubtful RHOA at baseline. Our study lacked sufficient statistical power to stratify associations by age. However, the descriptive subgroup statistics showed that hips with AD aged 61&#x02013;70 at baseline had an increased RR (1.70 95% CI 1.19&#x02013;2.44) of developing incident RHOA, which was lower in other age groups although the CI overlaps (age 40&#x02013;50 RR: 1.07 95% CI 0.53&#x02013;2.17, age 51&#x02013;60 RR: 1.40 95% CI 1.02&#x02013;1.93, age 70+ RR: 1.45 95% CI 0.81&#x02013;2.61). This finding suggests that younger individuals with AD may not be more at risk, but future studies with sufficient power should further analyze these associations.</p><p id="P35">The prevalence of AD defined by a WCEA &#x02264;25&#x000b0; in our study population was similar in women (25.8%) compared to men (24.3%) in the study population. Although acetabular undercoverage was equally common in men and women in our study, we found that the RR is significantly lower in men with AD to develop RHOA (RR 0.69 95% CI 0.39&#x02013;1.23) compared to women (RR 1.73 95% CI 1.37&#x02013;2.18). It has been hypothesized that women have different joint alignment and thus joint load distribution than men. Estrogen metabolism, or pregnancy related pelvic instability may play a role in sex differences.<sup><xref rid="R40" ref-type="bibr">40</xref></sup></p><p id="P36">We hypothesized that a higher overall body weight may lead to higher joint load and therefore increase the risk of RHOA in overweight individuals with AD. Descriptive statistics show a slightly increased RR for AD hips in individuals who have a BMI &#x0003c; 25 (RR 1.66 95% CI 1.18&#x02013;2.34) compared to AD hips of individuals with BMI &#x02265;25 (RR 1.42 1.09&#x02013;1.85) in our study population, but CIs overlap meaning this is likely not significant. Interestingly, a recent study in children found a negative association between being overweight and developing dysplasia.<sup><xref rid="R41" ref-type="bibr">41</xref></sup> A previous study in the Rotterdam Study also reported low BMI as a risk factor for AD hips to develop RHOA.<sup><xref rid="R24" ref-type="bibr">24</xref></sup></p><p id="P37">The sensitivity analysis excluding the MOST cohort, as this contained long-limb radiographs rather than AP pelvic radiographs, yielded similar results to the primary analysis. Excluding MOST led to an aOR of 1.89 (95%CI 1.45 &#x02212;2.47) for the association between AD and RHOA, compared to the primary analysis, which does include the MOST cohort of aOR 1.80 (95% CI 1.40&#x02013;2.34). By including the hips from the MOST cohort in the primary analysis, we argue that the reported aORs contribute to generalizable results considering the added variation of a different radiographic view. Furthermore, the CIs largely overlap, from which we conclude that there are no statistically important differences between the study population, including and excluding the hips from the MOST cohort.</p><p id="P38">Quantification of AD may have impacted the previously reported associations between AD and RHOA.<sup><xref rid="R25" ref-type="bibr">25</xref></sup> In the present study, WCEA rather than LCEA was employed, as we argue that the weight-bearing surface, rather than the entire bony femoral head coverage, is under stress as a result of AD. Secondly, the threshold to define AD also vary in the literature. We used a threshold of WCEA &#x02264;25&#x000b0; which indicates mild AD and should be kept in mind when interpreting the results. The association between AD when defined by WCEA &#x02264;20&#x000b0; increased, which may indicate that more severe AD increases the risk of developing RHOA. Finally, we found that most studies only use acetabular coverage as a measure of AD, but for the present study we examined if acetabular depth or roof inclination influenced the reported associations. We found that both acetabular undercoverage as well as a shallow acetabulum were significantly associated with RHOA at follow-up in the present population. Whether acetabular roof inclination is also associated with RHOA could not be concluded from the present study, but future studies with long-term follow-up and therefore likely a higher incidence of RHOA may shed light on this measurement as a predictor.</p><p id="P39">A comprehensive definition of hip OA in epidemiological studies is still lacking.<sup><xref rid="R42" ref-type="bibr">42</xref></sup> Commonly used RHOA classification systems are the KL and (modified) Croft grading systems,<sup><xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R42" ref-type="bibr">42</xref></sup> for which good ICCs (<bold>&#x003ba;</bold> = 0.55&#x02013;0.92) have been reported in the World COACH cohorts.<sup><xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R17" ref-type="bibr">17</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R42" ref-type="bibr">42</xref>,<xref rid="R43" ref-type="bibr">43</xref></sup> The inevitable variability in RHOA grading was corrected for in the logistic regression model by accounting for within-cohort effects. The incidence of RHOA in the present study of 2.01% (range per cohort 0.5&#x02013;13.4%) is relatively low compared to similar studies.<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R43" ref-type="bibr">43</xref>,<xref rid="R44" ref-type="bibr">44</xref></sup> Interestingly, the cohorts with the highest incidence of RHOA at follow-up (CHECK (22.6%), JoCo (10.9%) and Chingford (8.6%) were on average younger at baseline than the cohorts with the lowest incidence (OAI (0.5%), RS-II (0.4%) and RS-III (0.2%). The overall low incidence of incident RHOA is likely related to the exclusion of hips with doubtful RHOA at baseline.</p><p id="P40">The primary strength of the present study is the design. IPD meta-analysis created increased statistical power, reduced publication bias, and allowed for investigation of subgroup effects.<sup><xref rid="R45" ref-type="bibr">45</xref></sup> As RHOA is a heterogeneous disease, identifying subgroups for interventions is likely a promising way forward in clinical research. A second benefit of IPD meta-analysis compared to meta-analysis alone is that we were able to choose confounders for all included hips. This allowed us to correct for the same covariates across all cohorts and perform uniform analyses. IPD also helped improve data quality by combining studies with different follow-up and outcomes, to improve generalizability of findings.<sup><xref rid="R46" ref-type="bibr">46</xref>,<xref rid="R47" ref-type="bibr">47</xref></sup> A second strength is the use of multiple, uniform radiographic measurements to quantify AD. Although the WCEA proved to be the only measure of AD significantly associated with incident RHOA in our analysis, we argue that by additionally studying the ADR and mAI, we captured more of the AD characteristics compared to studies only employing a CEA.<sup><xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R35" ref-type="bibr">35</xref></sup> A third strength is the uniformity of automated measurements, which removed variability compared to manual measurements and allowed for objective AD measurements across all cohorts.<sup><xref rid="R9" ref-type="bibr">9</xref></sup></p><p id="P41">This study was subject to limitations. The primary limitation is the subjective nature of original OA grading systems, as they rely on subjective assessment of OA features. We accounted for variability in OA scores per cohort in our statistical model and argue that, as these grading systems are still primarily used in a clinical setting, our study represents best current clinical practice. It should also be kept in mind when interpreting the results that RHOA does not equate clinical hip OA.<sup><xref rid="R48" ref-type="bibr">48</xref></sup> A second limitation is the variety of radiographic protocols per cohort, such as supine vs. weight-bearing radiographs. However, a recent study showed that for JSN, no difference in measurements between weightbearing or supine AP radiographs was found.<sup><xref rid="R49" ref-type="bibr">49</xref></sup> A horizontal reference line allowed for standardization of all other measurements, which reduced variability to a minimum. A third limitation is the lack of statistical power to perform logistic regression in subgroups. As AD has been shown to be a risk factor in younger individuals to develop RHOA, and the number of individuals &#x02264;50 years of age was very limited in the present study.<sup><xref rid="R12" ref-type="bibr">12</xref></sup> The current results cannot be generalized to the young adult population (&#x02264;50 years). Prospective studies of younger populations are needed to study this further. A limitation of IPD meta-analysis is that it may become prone to selection bias when IPD are only sought for a specific subset of studies. The World COACH cohorts however have been recruited based on a systematic literature search, which has been repeated recently.<sup><xref rid="R50" ref-type="bibr">50</xref></sup> Clinicians, researchers, and patients are also actively involved to help identify studies that should be included in the consortium. We therefore argue that publication bias was minimized in our study. We used definitions of AD only in one plane, thereby potentially neglecting anatomical abnormalities that may exist at different planes simultaneously.<sup><xref rid="R51" ref-type="bibr">51</xref></sup> We argue however, that by using multiple measurements to define AD, we were still able to capture a wide array of anatomical variability, in line with current clinical practice.</p><p id="P42">In future studies, identification of modifiable risk factors is essential for prevention of hip OA, as well as improving quality of life by advancing individualized care and identification of new treatments. Hip dysplasia is recognized as a potentially modifiable risk factor. It has been hypothesized that there are two distinct forms of hip dysplasia; developmental dysplasia of the hip (DDH) which is diagnosed during infancy, and AD, which is diagnosed later in life.<sup><xref rid="R52" ref-type="bibr">52</xref></sup> A recent study found demographic differences between patients diagnosed with DDH in infancy and adults with AD, supporting this hypothesis.<sup><xref rid="R53" ref-type="bibr">53</xref></sup> Examination of newborns for hip instability exemplifies prevention for hip OA in DDH hips, as the plastic hip joint can be stabilized to produce a congruent joint. This study showed that AD in the adult population was highly prevalent depending on the definition used, but the association with RHOA in general may be weaker than previously thought. It is therefore warranted to further our understanding of which individuals with AD specifically are at high risk of developing hip OA, and, assuming that two distinct forms exist, investigate whether one form is clinically more relevant.</p><p id="P43">In conclusion, this study demonstrated that AD is a risk factor for incident RHOA in hips free of RHOA at baseline. This IPD meta-analysis allowed for a robust analysis of the association between AD and RHOA, due to the large sample size, uniform measurements of AD across all baseline radiographs, and harmonized outcome of RHOA. Identification of modifiable risk factors is essential for prevention of hip OA in the future, as well as improving quality of life by advancing individualized care and identification of new treatments.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>Supplementary Material 1</label><media xlink:href="NIHMS2093210-supplement-Supplementary_Material_1.docx" id="d67e832" position="anchor"/></supplementary-material><supplementary-material id="SD2" position="float" content-type="local-data"><label>Supplementary Material 2</label><media xlink:href="NIHMS2093210-supplement-Supplementary_Material_2.docx" id="d67e835" position="anchor"/></supplementary-material><supplementary-material id="SD3" position="float" content-type="local-data"><label>Supplementary Material 3</label><media xlink:href="NIHMS2093210-supplement-Supplementary_Material_3.pdf" id="d67e838" position="anchor"/></supplementary-material><p id="P45">Appendix A. Supporting information</p><p id="P46">Supplementary data associated with this article can be found in the online version at doi:<ext-link xlink:href="https://doi.org/10.1016/j.joca.2024.12.001" ext-link-type="uri">10.1016/j.joca.2024.12.001</ext-link>.</p></sec></body><back><ack id="S23"><title>Acknowledgments</title><p id="P47">We would like to thank all participants of each of the cohort studies that are involved in World COACH. We gratefully acknowledge all international organisations that collaborated with the cohort studies in World COACH, as well as the OARSI for endorsing the World COACH consortium.</p><sec id="S24"><title>Funding</title><p id="P48">The World COACH consortium has been funded through grants by the Dutch Arthritis Society (grant nr 21-1-205), the Dutch Research Council (NOW, Veni: 09150161910071), and Erasmus MC University Medical Center Rotterdam. CL is funded by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (223267/Z/21/Z). This research was funded in whole, or in part, by the Wellcome Trust [Grant number 223267/Z/21/Z]. For the purpose of open access, the authors have applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.</p></sec><sec id="S25"><title>CHECK</title><p id="P49">The CHECK study was initiated by the Dutch Arthritis Society and performed within: Erasmus Medical Center Rotterdam; Kennemer Gasthuis Haarlem; Leiden University Medical Center; Maastricht University Medical Center; Martini Hospital Groningen/Allied Health Care Center for Rheum. and Rehabilitation Groningen; Medical Spectrum Twente Enschede/Ziekenhuisgroep Twente Almelo; Reade, formerly Jan van Breemen Institute/VU Medical Center Amsterdam; St.Maartens-kliniek Nijmegen; University Medical Center Utrecht and Wilhelmina Hospital Assen.</p></sec><sec id="S26"><title>Chingford</title><p id="P50">We would like to thank all the participants of the Chingford Women Study, Professor Nigel Arden, Professor Tim Spector, Dr Deborah Hart, Mr Gem Lawson, Maxine Daniels and Alison Turner for their time and dedication and Arthritis Research UK for their funding support to the study and the Oxford NIHR Musculoskeletal Biomedical Research Unit for funding contributions.</p></sec><sec id="S27"><title>JoCo-OA</title><p id="P51">Support for data from the Johnston County Osteoarthritis Project was provided in part by: the Center for Disease Control and Prevention (CDC) U01DP006266 and U01DP003206; Association of Schools of Public Health/ CDC S043, S1734, S3486; and National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases P60AR30701, P60AR049465, P60AR064166, and P30AR072580.</p></sec><sec id="S28"><title>MOST</title><p id="P52">The MOST study was funded by the National Institutes of Health &#x02013; National Institute on Aging grants AG19069 (Michael Nevitt, University of California, San Francisco) AG18820 (David Felson, Boston University) AG18947 (Cora Lewis, University of Alabama at Birmingham) and AG18832 (James Torner, University of Iowa).</p></sec><sec id="S29"><title>OAI</title><p id="P53">The cohort, clinical data and image acquisitions used in these analyses were fund as the Osteoarthritis Initiative by the National Institutes of Health (NIH) through a Foundation for NIH public private partnership with GlaxoSmithKline, Merck &#x00026; Co., Inc., Novartis Pharmaceuticals Corporation, and Pfizer.</p></sec><sec id="S30"><title>Rotterdam Study</title><p id="P54">The Rotterdam Study is funded by Erasmus University Medical Center and Erasmus University, Rotterdam, The Netherlands Organisation for Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The authors are grateful to the study participants, the staff from the Rotterdam Study and the participating general practitioners and pharmacists.</p></sec><sec id="S31"><title>SOF</title><p id="P55">The Study of Osteoporotic Fractures (SOF) is supported by National Institutes of Health funding. The National Institute on Aging (NIA) provides support under the following grant numbers: R01 AG005407, R01 AR35582, R01 AR35583, R01 AR35584, R01 AG005394, R01 AG027574, and R01 AG027576.</p></sec><sec id="S32"><title>TASOAC</title><p id="P56">The TASOAC study was supported by the National Health and Medical Research Council of Australia, Tasmanian Community Fund, Masonic Centenary Medical Research Foundation, Royal Hobart Hospital Research Foundation and Arthritis Foundation of Australia.</p></sec></ack><fn-group><fn id="FN3"><p id="P57">Ethical approval</p><p id="P58">This study involves human participants but was excepted from ethical approval (Erasmus MC Medical Ethics Review Committee) as it uses previously collected observational data for which the participants had originally given informed consent, and all cohort studies included in this consortium already had ethics approval from their respective committees. Participants gave informed consent to participate in the study before taking part.</p></fn><fn id="FN4"><p id="P59">Patient and public involvement</p><p id="P60">Patient involvement is ongoing in the World COACH consortium as they co-determine and prioritize research questions to be answered within World COACH. World COACH researchers attend annual conferences for patients with OA in the Netherlands (Artrose Gezond) and engage in open dialog with OA patients to form research goals. The potential of the consortium to discover risk factors and potential treatment options are explained to patients, and both patients and public are encouraged to share ideas and questions they want answered through <ext-link xlink:href="http://www.worldcoachconsortium.com/" ext-link-type="uri">www.worldcoachconsortium.com</ext-link>.</p></fn><fn fn-type="COI-statement" id="FN5"><p id="P61">Declaration of competing interests</p><p id="P62">GJ reports personal fees from Novartis outside the submitted work. SBZ reports consulting fees from Pfizer Infirst Healthcare and personal fees for being a Deputy Editor for Osteoarthritis and Cartilage outside the submitted work. CL and TC report a patent for an image processing apparatus and method for fitting a deformable shape model to an image using random forest regression voting. CL reports licensing royalties for this patent from Optasia Medical outside the submitted work. AN is an associate editor for Osteoarthritis and Cartilage and is on the OARSI Board of Directors outside the submitted work. AM is on the Editorial Board for the British Journal of Sports Medicine and the Journal of Science and Medicine in Sport outside the submitted work. HW reports being a minority shareholder of Uplanner BV and Replasia BV outside the submitted work.</p></fn></fn-group><sec sec-type="data-availability" id="S22"><title>Data availability</title><p id="P44">Data are available upon reasonable request. Data may be obtained from a third party and are not publicly available. We encourage the use of data by third parties, although this is subject to approval by the steering committees of the World COACH consortium and the participating cohorts, as well as to legal boundaries regarding data ownership. A standardized data request form is available for which will be reviewed uniformly in order to consistetenly handle World COACH data requests.</p></sec><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Hunter</surname><given-names>DJ</given-names></name>, <name><surname>March</surname><given-names>L</given-names></name>, <name><surname>Chew</surname><given-names>M</given-names></name>. <article-title>Osteoarthritis in 2020 and beyond: a <italic toggle="yes">Lancet</italic> Commission</article-title>. <source>Lancet</source>
<year>2020</year>;<volume>396</volume>(<issue>10264</issue>):<fpage>1711</fpage>&#x02013;<lpage>2</lpage>.<pub-id pub-id-type="pmid">33159851</pub-id>
</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="book"><source>Health economics in the field of osteoarthritis: an expert&#x02019;s consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)</source>. <publisher-name>Seminars in arthritis and rheumatism: Elsevier</publisher-name>; <year>2013</year>.</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Harris</surname><given-names>WH</given-names></name>. <article-title>Etiology of osteoarthritis of the hip</article-title>. <source>Clin Orthop Relat Res</source>
<year>1986</year>;<volume>213</volume>:<fpage>20</fpage>&#x02013;<lpage>33</lpage>.</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Baker-LePain</surname><given-names>JC</given-names></name>, <name><surname>Lane</surname><given-names>NE</given-names></name>. <article-title>Relationship between joint shape and the development of osteoarthritis</article-title>. <source>Curr Opin Rheumatol</source>
<year>2010</year>;<volume>22</volume>(<issue>5</issue>):<fpage>538</fpage>.<pub-id pub-id-type="pmid">20644480</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Agricola</surname><given-names>R</given-names></name>, <name><surname>Heijboer</surname><given-names>MP</given-names></name>, <name><surname>Bierma-Zeinstra</surname><given-names>S</given-names></name>, <name><surname>Verhaar</surname><given-names>JAN</given-names></name>, <name><surname>Weinans</surname><given-names>H</given-names></name>, <name><surname>Waarsing</surname><given-names>JH</given-names></name>. <article-title>Cam impingement causes osteoarthritis of the hip: a nationwide prospective cohort study (CHECK)</article-title>. <source>Ann Rheum Dis</source>
<year>2013</year>;<volume>72</volume>(<issue>6</issue>):<fpage>918</fpage>.<pub-id pub-id-type="pmid">22730371</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Ganz</surname><given-names>R</given-names></name>, <name><surname>Leunig</surname><given-names>M</given-names></name>, <name><surname>Leunig-Ganz</surname><given-names>K</given-names></name>, <name><surname>Harris</surname><given-names>WH</given-names></name>. <article-title>The Etiology of Osteoarthritis of the Hip</article-title>. <source>Clin Orthop</source>
<year>2008</year>;<volume>466</volume>(<issue>2</issue>):<fpage>264</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">18196405</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Jacobsen</surname><given-names>S</given-names></name>, <name><surname>Sonne-Holm</surname><given-names>S</given-names></name>. <article-title>Hip dysplasia: a significant risk factor for the development of hip osteoarthritis. A cross-sectional survey</article-title>. <source>Rheumatology (Oxford)</source>
<year>2004</year>;<volume>44</volume>(<issue>2</issue>):<fpage>211</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">15479751</pub-id>
</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Agricola</surname><given-names>R</given-names></name>, <name><surname>Heijboer</surname><given-names>MP</given-names></name>, <name><surname>Roze</surname><given-names>RH</given-names></name>, <name><surname>Reijman</surname><given-names>M</given-names></name>, <name><surname>Bierma-Zeinstra</surname><given-names>SMA</given-names></name>, <name><surname>Verhaar</surname><given-names>JAN</given-names></name>, <etal/>
<article-title>Pincer deformity does not lead to osteoarthritis of the hip whereas acetabular dysplasia does: acetabular coverage and development of osteoarthritis in a nationwide prospective cohort study (CHECK)</article-title>. <source>Osteoarthritis Cartilage</source>
<year>2013</year>;<volume>21</volume>(<issue>10</issue>):<fpage>1514</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">23850552</pub-id>
</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Casartelli</surname><given-names>NC</given-names></name>, <name><surname>Maffiuletti</surname><given-names>NA</given-names></name>, <name><surname>Valenzuela</surname><given-names>PL</given-names></name>, <name><surname>Grassi</surname><given-names>A</given-names></name>, <name><surname>Ferrari</surname><given-names>E</given-names></name>, <name><surname>van Buuren</surname><given-names>MMA</given-names></name>, <etal/>
<article-title>Is hip morphology a risk factor for developing hip osteoarthritis? A systematic review with meta-analysis</article-title>. <source>Osteoarthritis Cartilage</source>
<year>2021</year>;<volume>29</volume>(<issue>9</issue>):<fpage>1252</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">34171473</pub-id>
</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Ganz</surname><given-names>R</given-names></name>, <name><surname>Parvizi</surname><given-names>J</given-names></name>, <name><surname>Beck</surname><given-names>M</given-names></name>, <name><surname>Leunig</surname><given-names>M</given-names></name>, <name><surname>N&#x000f6;tzli</surname><given-names>H</given-names></name>, <name><surname>Siebenrock</surname><given-names>KA</given-names></name>. <article-title>Femoroacetabular Impingement: A Cause for Osteoarthritis of the Hip</article-title>. <source>Clin Orthop Relat Res</source>
<year>2003</year>:<fpage>417</fpage>.</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Saberi Hosnijeh</surname><given-names>F</given-names></name>, <name><surname>Zuiderwijk</surname><given-names>ME</given-names></name>, <name><surname>Versteeg</surname><given-names>M</given-names></name>, <name><surname>Smeele</surname><given-names>HT</given-names></name>, <name><surname>Hofman</surname><given-names>A</given-names></name>, <name><surname>Uitterlinden</surname><given-names>AG</given-names></name>, <etal/>
<article-title>Cam deformity and acetabular dysplasia as risk factors for hip osteoarthritis</article-title>. <source>Arthritis Rheumatol</source>
<year>2017</year>
<month>Jan</month>;<volume>69</volume>(<issue>1</issue>):<fpage>86</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">27696746</pub-id>
</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="book"><source>Acetabular dysplasia and the risk of developing hip osteoarthritis at 2, 5, 8, and 10 years follow-up in a prospective nationwide cohort study (CHECK)</source>. <publisher-name>Seminars in Arthritis and Rheumatism: Elsevier</publisher-name>; <year>2023</year>.</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Faber</surname><given-names>BG</given-names></name>, <name><surname>Ebsim</surname><given-names>R</given-names></name>, <name><surname>Saunders</surname><given-names>FR</given-names></name>, <name><surname>Frysz</surname><given-names>M</given-names></name>, <name><surname>Gregory</surname><given-names>JS</given-names></name>, <name><surname>Aspden</surname><given-names>RM</given-names></name>, <etal/>
<article-title>Cam morphology but neither acetabular dysplasia nor pincer morphology is associated with osteophytosis throughout the hip: findings from a cross-sectional study in UK Biobank</article-title>. <source>Osteoarthritis Cartilage</source>
<year>2021</year>;<volume>29</volume>(<issue>11</issue>):<fpage>1521</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">34419604</pub-id>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>van Buuren</surname><given-names>MMA</given-names></name>, <name><surname>Riedstra</surname><given-names>NS</given-names></name>, <name><surname>van den Berg</surname><given-names>MA</given-names></name>, <name><surname>Boel</surname><given-names>F</given-names></name>, <name><surname>Ahedi</surname><given-names>H</given-names></name>, <name><surname>Arbabi</surname><given-names>V</given-names></name>, <name><surname>Arden</surname><given-names>NK</given-names></name>, <name><surname>Bierma-Zeinstra</surname><given-names>SMA</given-names></name>, <name><surname>Boer</surname><given-names>CG</given-names></name>, <name><surname>Cicuttini</surname><given-names>FM</given-names></name>, <name><surname>Cootes</surname><given-names>TF</given-names></name>, <name><surname>Crossley</surname><given-names>KM</given-names></name>, <name><surname>Felson</surname><given-names>DT</given-names></name>, <name><surname>Gielis</surname><given-names>WP</given-names></name>, <name><surname>Heerey</surname><given-names>JJ</given-names></name>, <name><surname>Jones</surname><given-names>G</given-names></name>, <name><surname>Kluzek</surname><given-names>S</given-names></name>, <name><surname>Lane</surname><given-names>NE</given-names></name>, <name><surname>Lindner</surname><given-names>C</given-names></name>, <name><surname>Lynch</surname><given-names>JA</given-names></name>, <name><surname>van Meurs</surname><given-names>JBJ</given-names></name>, <name><surname>Mosler</surname><given-names>A</given-names></name>, <name><surname>Nelson</surname><given-names>AE</given-names></name>, <name><surname>Nevitt</surname><given-names>MC</given-names></name>, <name><surname>Oei</surname><given-names>EHG</given-names></name>, <name><surname>Runhaar</surname><given-names>J</given-names></name>, <name><surname>Tang</surname><given-names>J</given-names></name>, <name><surname>Weinans</surname><given-names>H</given-names></name>, <name><surname>Agricola</surname><given-names>R</given-names></name>. <article-title>Cohort profile: Worldwide Collaboration on OsteoArthritis prediCtion for the Hip (World COACH); an international consortium of prospective cohort studies with individual participant data on hip osteoarthritis</article-title>. <source>BMJ Open</source>.</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Wesseling</surname><given-names>J</given-names></name>, <name><surname>Boers</surname><given-names>M</given-names></name>, <name><surname>Viergever</surname><given-names>MA</given-names></name>, <name><surname>Hilberdink</surname><given-names>WKHA</given-names></name>, <name><surname>Lafeber</surname><given-names>FPJG</given-names></name>, <name><surname>Dekker</surname><given-names>J</given-names></name>, <etal/>
<article-title>Cohort Profile: Cohort Hip and Cohort Knee (CHECK) study</article-title>. <source>Int J Epidemiol</source>
<year>2016</year>;<volume>45</volume>(<issue>1</issue>):<fpage>36</fpage>&#x02013;<lpage>44</lpage>. <month>Feb</month>.<pub-id pub-id-type="pmid">25172137</pub-id>
</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Jordan</surname><given-names>JM</given-names></name>, <name><surname>Linder</surname><given-names>GF</given-names></name>, <name><surname>Renner</surname><given-names>JB</given-names></name>, <name><surname>Fryer</surname><given-names>JG</given-names></name>. <article-title>The impact of arthritis in rural populations</article-title>. <source>Arthritis Care Res</source>
<year>1995</year>
<month>Dec</month>;<volume>8</volume>(<issue>4</issue>):<fpage>242</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">8605262</pub-id>
</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Segal</surname><given-names>NA</given-names></name>, <name><surname>Nevitt</surname><given-names>MC</given-names></name>, <name><surname>Gross</surname><given-names>KD</given-names></name>, <name><surname>Hietpas</surname><given-names>J</given-names></name>, <name><surname>Glass</surname><given-names>NA</given-names></name>, <name><surname>Lewis</surname><given-names>CE</given-names></name>, <etal/>
<article-title>The Multicenter Osteoarthritis Study: opportunities for rehabilitation research</article-title>. <source>PM R</source>
<year>2013</year>
<month>Aug</month>;<volume>5</volume>(<issue>8</issue>):<fpage>647</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">23953013</pub-id>
</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="other"><name><surname>Nevitt</surname><given-names>MCFD</given-names></name>, <name><surname>Lester</surname><given-names>G</given-names></name>. <collab>The Osteoarthritis Initiative</collab>. <source>Protocol for the cohort study.;V 1.1 6.21.06 (National Institute of Arthritis, Musculoskeletal and Skin Diseases.)</source> Date accessed: <date-in-citation>12-09-23</date-in-citation>.</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Hofman</surname><given-names>A</given-names></name>, <name><surname>Darwish Murad</surname><given-names>S</given-names></name>, <name><surname>van Duijn</surname><given-names>CM</given-names></name>, <name><surname>Franco</surname><given-names>OH</given-names></name>, <name><surname>Goedegebure</surname><given-names>A</given-names></name>, <name><surname>Ikram</surname><given-names>MA</given-names></name>, <etal/>
<article-title>The Rotterdam Study: 2014 objectives and design update</article-title>. <source>Eur J Epidemiol</source>
<year>2013</year>;<volume>28</volume>(<issue>11</issue>):<fpage>889</fpage>&#x02013;<lpage>926</lpage>.<pub-id pub-id-type="pmid">24258680</pub-id>
</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Lindner</surname><given-names>C</given-names></name>, <name><surname>Thiagarajah</surname><given-names>S</given-names></name>, <name><surname>Wilkinson</surname><given-names>JM</given-names></name>, <name><surname>Wallis</surname><given-names>GA</given-names></name>, <name><surname>Cootes</surname><given-names>TF</given-names></name>. <article-title>arcOGEN Consortium. Fully automatic segmentation of the proximal femur using random forest regression voting</article-title>. <source>IEEE Trans Med Imaging</source>
<year>2013</year>;<volume>32</volume>(<issue>8</issue>):<fpage>1462</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">23591481</pub-id>
</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="other"><name><surname>Boel</surname><given-names>F</given-names></name>, <name><surname>Riedstra</surname><given-names>NS</given-names></name>, <name><surname>Tang</surname><given-names>J</given-names></name>, <name><surname>Hanff</surname><given-names>DF</given-names></name>, <name><surname>Ahedi</surname><given-names>H</given-names></name>, <name><surname>Arden</surname><given-names>N</given-names></name>, <name><surname>Bierma-Zeinstra</surname><given-names>SMA</given-names></name>, <name><surname>van Buuren</surname><given-names>MMA</given-names></name>, <name><surname>Cicuttini</surname><given-names>FM</given-names></name>, <name><surname>Cootes</surname><given-names>TF</given-names></name>, <name><surname>Crossley</surname><given-names>K</given-names></name>, <name><surname>Felson</surname><given-names>DT</given-names></name>, <name><surname>Gielis</surname><given-names>WP</given-names></name>, <name><surname>Heerey</surname><given-names>J</given-names></name>, <name><surname>Jones</surname><given-names>G</given-names></name>, <name><surname>Kluzek</surname><given-names>S</given-names></name>, <name><surname>Lane</surname><given-names>NE</given-names></name>, <name><surname>Lindner</surname><given-names>C</given-names></name>, <name><surname>Lynch</surname><given-names>J</given-names></name>, <name><surname>van Meurs</surname><given-names>J</given-names></name>, <name><surname>Nelson</surname><given-names>AE</given-names></name>, <name><surname>Mosler</surname><given-names>A</given-names></name>, <name><surname>Nevitt</surname><given-names>MC</given-names></name>, <name><surname>Oei</surname><given-names>EH</given-names></name>, <name><surname>Runhaar</surname><given-names>J</given-names></name>, <name><surname>Weinans</surname><given-names>H</given-names></name>, <name><surname>Agricola</surname><given-names>R</given-names></name>. <source>Reliability and Agreement of Manual and Automated Morphological Radiographic Hip Measurements</source>. <year>2024</year>.</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Boel</surname><given-names>F</given-names></name>, <name><surname>de Vos-Jakobs</surname><given-names>S</given-names></name>, <name><surname>Riedstra</surname><given-names>NS</given-names></name>, <name><surname>Lindner</surname><given-names>C</given-names></name>, <name><surname>Runhaar</surname><given-names>J</given-names></name>, <name><surname>Bierma-Zeinstra</surname><given-names>SMA</given-names></name>, <etal/>
<article-title>Automated radiographic hip morphology measurements: An open-access method</article-title>. <source>Osteoarthritis Imaging</source>
<year>2024</year>;<volume>4</volume>(<issue>2</issue>), <fpage>100181</fpage>.<pub-id pub-id-type="pmid">39239618</pub-id>
</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Reijman</surname><given-names>M</given-names></name>, <name><surname>Hazes</surname><given-names>J</given-names></name>, <name><surname>Pols</surname><given-names>H</given-names></name>, <name><surname>Koes</surname><given-names>BW</given-names></name>, <name><surname>Bierma-Zeinstra</surname><given-names>S</given-names></name>. <article-title>Acetabular dysplasia predicts incident osteoarthritis of the hip: the Rotterdam study</article-title>. <source>Arthritis Rheum</source>
<year>2005</year>;<volume>52</volume>(<issue>3</issue>):<fpage>787</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">15751071</pub-id>
</mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Wilkin</surname><given-names>GP</given-names></name>, <name><surname>Ibrahim</surname><given-names>MM</given-names></name>, <name><surname>Smit</surname><given-names>KM</given-names></name>, <name><surname>Beaul&#x000e9;</surname><given-names>PE</given-names></name>. <article-title>A contemporary definition of hip dysplasia and structural instability: toward a comprehensive classification for acetabular dysplasia</article-title>. <source>J Arthroplasty</source>
<year>2017</year>;<volume>32</volume>(<issue>9</issue>):<fpage>S20</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">28389135</pub-id>
</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Kellgren</surname><given-names>JH</given-names></name>, <name><surname>Lawrence</surname><given-names>J</given-names></name>. <article-title>Radiological assessment of osteo-arthrosis</article-title>. <source>Ann Rheum Dis</source>
<year>1957</year>;<volume>16</volume>(<issue>4</issue>):<fpage>494</fpage>.<pub-id pub-id-type="pmid">13498604</pub-id>
</mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Croft</surname><given-names>P</given-names></name>, <name><surname>Cooper</surname><given-names>C</given-names></name>, <name><surname>Wickham</surname><given-names>C</given-names></name>, <name><surname>Coggon</surname><given-names>D</given-names></name>. <article-title>Defining osteoarthritis of the hip for epidemiologic studies</article-title>. <source>Am J Epidemiol</source>
<year>1990</year>;<volume>132</volume>(<issue>3</issue>):<fpage>514</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">2389755</pub-id>
</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Joseph</surname><given-names>GB</given-names></name>, <name><surname>Hilton</surname><given-names>JF</given-names></name>, <name><surname>Jungmann</surname><given-names>PM</given-names></name>, <name><surname>Lynch</surname><given-names>JA</given-names></name>, <name><surname>Lane</surname><given-names>NE</given-names></name>, <name><surname>Liu</surname><given-names>F</given-names></name>, <etal/>
<article-title>Do persons with asymmetric hip pain or radiographic hip OA have worse pain and structure outcomes in the knee opposite the more affected hip?</article-title>
<source>Data from the Osteoarthritis Initiative</source>
<year>2016</year>;<volume>24</volume>(<issue>3</issue>):<fpage>427</fpage>&#x02013;<lpage>35</lpage>.</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Lane</surname><given-names>NE</given-names></name>. <source>We Challenged the Kellgren and Lawrence Radiographic Scoring Method and Came Up With Some Interesting Epidemiology for Osteoarthritis of the Hip</source>. <year>2023</year>;<volume>19</volume>(<issue>4</issue>):<fpage>402</fpage>&#x02013;<lpage>406</lpage>.</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Culvenor</surname><given-names>AG</given-names></name>, <name><surname>Engen</surname><given-names>CN</given-names></name>, <name><surname>&#x000d8;iestad</surname><given-names>BE</given-names></name>, <name><surname>Engebretsen</surname><given-names>L</given-names></name>, <name><surname>Risberg</surname><given-names>MA</given-names></name>. <source>Defining the presence of radiographic knee osteoarthritis: a comparison between the Kellgren and Lawrence system and OARSI atlas criteria</source>. <year>2015</year>;<volume>23</volume>(<issue>12</issue>):<fpage>3532</fpage>&#x02013;<lpage>3539</lpage>.</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Lane</surname><given-names>NE</given-names></name>, <name><surname>Nevitt</surname><given-names>MC</given-names></name>, <name><surname>Hochberg</surname><given-names>MC</given-names></name>, <name><surname>Hung</surname><given-names>Y</given-names></name>, <name><surname>Palermo</surname><given-names>L</given-names></name>. <source>Progression of radiographic hip osteoarthritis over eight years in a community sample of elderly white women</source>. <year>2004</year>;<volume>50</volume>(<issue>5</issue>):<fpage>1477</fpage>&#x02013;<lpage>1486</lpage>.</mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="other"><name><surname>Bates</surname><given-names>D</given-names></name>, <name><surname>M&#x000e4;chler</surname><given-names>M</given-names></name>, <name><surname>Bolker</surname><given-names>B</given-names></name>, <name><surname>Walker</surname><given-names>S</given-names></name>. <source>Fitting Linear Mixed-Effects Models Using lme4</source>. <year>2015</year>.</mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="other"><name><surname>Rizopoulos</surname><given-names>Dimitris</given-names></name>. <source>Generalized Linear Mixed Models using Adaptive Gaussian Quadrature</source>.</mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="other"><name><surname>Wickham</surname><given-names>H</given-names></name>
<source>ggplot2: Elegant Graphics for Data Analysis</source>. <year>2016</year>.</mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Thomas</surname><given-names>G</given-names></name>, <name><surname>Palmer</surname><given-names>A</given-names></name>, <name><surname>Batra</surname><given-names>RN</given-names></name>, <name><surname>Kiran</surname><given-names>A</given-names></name>, <name><surname>Hart</surname><given-names>D</given-names></name>, <name><surname>Spector</surname><given-names>T</given-names></name>, <etal/>
<article-title>Subclinical deformities of the hip are significant predictors of radiographic osteoarthritis and joint replacement in women. A 20 year longitudinal cohort study</article-title>. <source>Osteoarthritis Cartilage</source>
<year>2014</year>;<volume>22</volume>(<issue>10</issue>):<fpage>1504</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">25047637</pub-id>
</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Casta&#x000f1;o-Betancourt</surname><given-names>MC</given-names></name>, <name><surname>Van Meurs</surname><given-names>J</given-names></name>, <name><surname>Bierma-Zeinstra</surname><given-names>S</given-names></name>, <name><surname>Rivadeneira</surname><given-names>F</given-names></name>, <name><surname>Hofman</surname><given-names>A</given-names></name>, <name><surname>Weinans</surname><given-names>H</given-names></name>, <etal/>
<source>The contribution of hip geometry to the prediction of hip osteoarthritis</source>. <year>2013</year>;<volume>21</volume>(<issue>10</issue>):<fpage>1530</fpage>&#x02013;<lpage>1536</lpage>.</mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>Cooperman</surname><given-names>DR</given-names></name>, <name><surname>Wallensten</surname><given-names>R</given-names></name>, <name><surname>Stulberg</surname><given-names>SD</given-names></name>. <article-title>Acetabular dysplasia in the adult</article-title>. <source>Clin Orthop</source>
<year>1983</year>;<volume>175</volume>:<fpage>79</fpage>&#x02013;<lpage>85</lpage>.</mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><name><surname>Jacobsen</surname><given-names>S</given-names></name>, <name><surname>Sonne-Holm</surname><given-names>S</given-names></name>, <name><surname>S&#x000f8;balle</surname><given-names>K</given-names></name>, <name><surname>Gebuhr</surname><given-names>P</given-names></name>, <name><surname>Lund</surname><given-names>B</given-names></name>. <article-title>Joint space width in dysplasia of the hip: a case-control study of 81 adults followed for ten years</article-title>. <source>J Bone Joint Surg Br</source>
<year>2005</year>;<volume>87</volume>(<issue>4</issue>):<fpage>471</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">15795195</pub-id>
</mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><name><surname>Nair</surname><given-names>AS</given-names></name>. <article-title>Publication bias - Importance of studies with negative results!</article-title>. <source>Indian J Anaesth</source>
<year>2019</year>
<month>Jun</month>;<volume>63</volume>(<issue>6</issue>):<fpage>505</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">31263309</pub-id>
</mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="other"><name><surname>Loder</surname><given-names>RT</given-names></name>, <name><surname>Skopelja</surname><given-names>EN</given-names></name>. <source>The epidemiology and demographics of hip dysplasia</source>. <year>2011</year>.</mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><name><surname>Chung</surname><given-names>WK</given-names></name>, <name><surname>de Vos-Jakobs</surname><given-names>S</given-names></name>, <name><surname>Rivadeneira</surname><given-names>F</given-names></name>, <name><surname>Bierma-Zeinstra</surname><given-names>SM</given-names></name>, <name><surname>Waarsing</surname><given-names>JH</given-names></name>. <source>The association of BMI and physical activity on acetabular dysplasia in children</source>. <year>2021</year>;<volume>29</volume>(<issue>1</issue>):<fpage>50</fpage>&#x02013;<lpage>58</lpage>.</mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><name><surname>Reijman</surname><given-names>M</given-names></name>, <name><surname>Hazes</surname><given-names>J</given-names></name>, <name><surname>Koes</surname><given-names>BW</given-names></name>, <name><surname>Verhagen</surname><given-names>AP</given-names></name>, <name><surname>Bierma-Zeinstra</surname><given-names>S</given-names></name>. <article-title>Validity, reliability, and applicability of seven definitions of hip osteoarthritis used in epidemiological studies: a systematic appraisal</article-title>. <source>Ann Rheum Dis</source>
<year>2004</year>;<volume>63</volume>(<issue>3</issue>):<fpage>226</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">14962953</pub-id>
</mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal"><name><surname>Lane</surname><given-names>NE</given-names></name>, <name><surname>Lin</surname><given-names>P</given-names></name>, <name><surname>Christiansen</surname><given-names>L</given-names></name>, <name><surname>Gore</surname><given-names>LR</given-names></name>, <name><surname>Williams</surname><given-names>EN</given-names></name>, <name><surname>Hochberg</surname><given-names>MC</given-names></name>, <etal/>
<article-title>Association of mild acetabular dysplasia with an increased risk of incident hip osteoarthritis in elderly white women: the study of osteoporotic fractures</article-title>. <source>Arthritis Rheum</source>
<year>2000</year>
<month>Feb</month>;<volume>43</volume>(<issue>2</issue>):<fpage>400</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">10693881</pub-id>
</mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal"><name><surname>Iidaka</surname><given-names>T</given-names></name>, <name><surname>Muraki</surname><given-names>S</given-names></name>, <name><surname>Oka</surname><given-names>H</given-names></name>, <name><surname>Horii</surname><given-names>C</given-names></name>, <name><surname>Kawaguchi</surname><given-names>H</given-names></name>, <name><surname>Nakamura</surname><given-names>K</given-names></name>, <etal/>
<source>Incidence rate and risk factors for radiographic hip osteoarthritis in Japanese men and women: a 10-year follow-up of the ROAD study</source>. <year>2020</year>;<volume>28</volume>(<issue>2</issue>):<fpage>182</fpage>&#x02013;<lpage>188</lpage>.</mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><name><surname>Riley</surname><given-names>RD</given-names></name>, <name><surname>Debray</surname><given-names>TP</given-names></name>, <name><surname>Fisher</surname><given-names>D</given-names></name>, <name><surname>Hattle</surname><given-names>M</given-names></name>, <name><surname>Marlin</surname><given-names>N</given-names></name>, <name><surname>Hoogland</surname><given-names>J</given-names></name>, <etal/>
<article-title>Individual participant data meta-analysis to examine interactions between treatment effect and participant-level covariates: statistical recommendations for conduct and planning</article-title>. <source>Stat Med</source>
<year>2020</year>;<volume>39</volume>(<issue>15</issue>):<fpage>2115</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="pmid">32350891</pub-id>
</mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal"><name><surname>Sud</surname><given-names>S</given-names></name>, <name><surname>Douketis</surname><given-names>J</given-names></name>. <article-title>The devil is in the details&#x02026; or not? A primer on individual patient data meta-analysis</article-title>. <source>Evid Based Med</source>
<year>2009</year>;<volume>14</volume>(<issue>4</issue>):<fpage>100</fpage>&#x02013;<lpage>1</lpage>.<pub-id pub-id-type="pmid">19648417</pub-id>
</mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal"><name><surname>Bujkiewicz</surname><given-names>S</given-names></name>, <name><surname>Thompson</surname><given-names>JR</given-names></name>, <name><surname>Sutton</surname><given-names>AJ</given-names></name>, <name><surname>Cooper</surname><given-names>NJ</given-names></name>, <name><surname>Harrison</surname><given-names>MJ</given-names></name>, <name><surname>Symmons</surname><given-names>DP</given-names></name>, <etal/>
<article-title>Multivariate meta-analysis of mixed outcomes: a Bayesian approach</article-title>. <source>Stat Med</source>
<year>2013</year>;<volume>32</volume>(<issue>22</issue>):<fpage>3926</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="pmid">23630081</pub-id>
</mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="journal"><name><surname>Bessa</surname><given-names>FS</given-names></name>, <name><surname>Williams</surname><given-names>BT</given-names></name>, <name><surname>Polce</surname><given-names>EM</given-names></name>, <name><surname>Maheshwer</surname><given-names>B</given-names></name>, <name><surname>Williams</surname><given-names>JC</given-names></name>, <name><surname>Nho</surname><given-names>SJ</given-names></name>, <etal/>
<article-title>No Differences in Hip Joint Space Measurements Between Weightbearing or Supine Anteroposterior Pelvic Radiographs</article-title>. <source>Arthroscopy</source>
<year>2020</year>;<volume>36</volume>(<issue>11</issue>):<fpage>2843</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">32735940</pub-id>
</mixed-citation></ref><ref id="R48"><label>48.</label><mixed-citation publication-type="journal"><name><surname>Herfkens</surname><given-names>J</given-names></name>, <name><surname>van Buuren</surname><given-names>MMA</given-names></name>, <name><surname>Riedstra</surname><given-names>NS</given-names></name>, <name><surname>Verhaar</surname><given-names>JAN</given-names></name>, <name><surname>Mascarenhas</surname><given-names>VV</given-names></name>, <name><surname>Agricola</surname><given-names>R</given-names></name>. <article-title>Adding false-profile radiographs improves detection of developmental dysplasia of the hip, data from the CHECK cohort</article-title>. <source>J Hip Preserv Surg</source>
<year>2022</year>. <fpage>hnac008</fpage>.</mixed-citation></ref><ref id="R49"><label>49.</label><mixed-citation publication-type="journal"><name><surname>Wynne-Davies</surname><given-names>R</given-names></name>
<article-title>Acetabular dysplasia and familial joint laxity: two etiological factors in congenital dislocation of the hip. A review of 589 patients and their families</article-title>. <source>J Bone Joint Surg Br</source>
<year>1970</year>;<volume>52</volume>(<issue>4</issue>):<fpage>704</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">5487570</pub-id>
</mixed-citation></ref><ref id="R50"><label>50.</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>CB</given-names></name>, <name><surname>Mata-Fink</surname><given-names>A</given-names></name>, <name><surname>Millis</surname><given-names>MB</given-names></name>, <name><surname>Kim</surname><given-names>Y</given-names></name>. <source>Demographic differences in adolescent-diagnosed and adult-diagnosed acetabular dysplasia compared with infantile developmental dysplasia of the hip</source>. <year>2013</year>;<volume>33</volume>(<issue>2</issue>):<fpage>107</fpage>&#x02013;<lpage>111</lpage>.</mixed-citation></ref><ref id="R51"><label>51.</label><mixed-citation publication-type="journal"><name><surname>Herfkens</surname><given-names>J</given-names></name>, <name><surname>van Buuren</surname><given-names>MM</given-names></name>, <name><surname>Riedstra</surname><given-names>NS</given-names></name>, <name><surname>Verhaar</surname><given-names>JA</given-names></name>, <name><surname>Mascarenhas</surname><given-names>VV</given-names></name>, <name><surname>Agricola</surname><given-names>R</given-names></name>. <article-title>Adding false-profile radiographs improves detection of developmental dysplasia of the hip, data from the CHECK cohort</article-title>. <source>J Hip Preserv Surg</source>
<year>2022</year>;<volume>9</volume>(<issue>1</issue>):<fpage>3</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">35651710</pub-id>
</mixed-citation></ref><ref id="R52"><label>52.</label><mixed-citation publication-type="journal"><name><surname>Wynne-Davies</surname><given-names>R</given-names></name>
<article-title>Acetabular dysplasia and familial joint laxity: two etiological factors in congenital dislocation of the hip: a review of 589 patients and their families</article-title>. <source>J Bone Joint Surg Br</source>
<year>1970</year>;<volume>52</volume>(<issue>4</issue>):<fpage>704</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">5487570</pub-id>
</mixed-citation></ref><ref id="R53"><label>53.</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>CB</given-names></name>, <name><surname>Mata-Fink</surname><given-names>A</given-names></name>, <name><surname>Millis</surname><given-names>MB</given-names></name>, <name><surname>Kim</surname><given-names>YJ</given-names></name>. <article-title>Demographic differences in adolescent-diagnosed and adult-diagnosed acetabular dysplasia compared with infantile developmental dysplasia of the hip</article-title>. <source>J Pediatr Orthop</source>
<year>2013</year>;<volume>33</volume>(<issue>2</issue>):<fpage>107</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">23389561</pub-id>
</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Fig. 1</label><caption><p id="P63">Anteroposterior in pelvic radiographs with three radiographic measurements to define AD. <bold>A: The acetabular depth-width ratio (ADR)</bold>: The acetabular width was defined as a line across the length of the acetabular opening, extending from the lateral edge of the acetabulum to the pelvic teardrop. Next, the acetabular depth was determined by constructing a line perpendicular to the acetabular width, extending from the most medial point of the sourcil. The ADR is defined as the ratio of the depth to the width, multiplied by 1000. <bold>B: The Center Edge Angle of Wiberg (WCEA)</bold>: To determine the center of the femoral head, a best-fitting circle is outlined around the femoral head based on the SSM points. The WCEA is then formed by a line drawn vertically through the center of the femoral head, perpendicular to the horizontal reference line, the second is drawn from the center of the femoral head to the most lateral weight-bearing part of the sourcil. <bold>C: The modified acetabular index (mAI)</bold>: The mAI measures the acetabular roof inclination. The measure is modified, as the original acetabular index is applied to hips with an open triradiate cartilage. The mAI measures inclination from the medial sourcil to the lateral bony part of the acetabulum. <bold>Horizontal reference line</bold> (B +C): To correct for pelvic rotation, a horizontal reference line is calculated based on the average of 4 lines, between 1) both femoral head centers, 2) the most cranial points of the foramen obturator, 3) the most caudal points of the ischial tuberosity and 4) the most caudal points of the pelvic teardrop.</p></caption><graphic xlink:href="nihms-2093210-f0001" position="float"/></fig><fig position="float" id="F2"><label>Fig. 2</label><caption><p id="P64">Flow of hips from consortium inclusion to final study population. OA: osteoarthritis. LCEA: lateral center edge angle. AP: anteroposterior. BMI: body mass index.</p></caption><graphic xlink:href="nihms-2093210-f0002" position="float"/></fig><fig position="float" id="F3"><label>Fig. 3</label><caption><p id="P65">Marginal probabilities of RHOA score within 4&#x02013;8 years for women aged 62 years and BMI of 27.4 kg/m<sup>2</sup> in hips with AD (WCEA &#x02264;25&#x000b0;) or without AD. The probabilities were marginalized over the random effects, i.e., cohort and individual and the model was adjusted for age, BMI, biological sex, and hips side.</p></caption><graphic xlink:href="nihms-2093210-f0003" position="float"/></fig><table-wrap position="float" id="T1" orientation="landscape"><label>Table I</label><caption><p id="P66">Baseline characteristic of included hips, stratified per cohort.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="left" valign="middle" rowspan="1" colspan="1">CHECK</th><th align="left" valign="middle" rowspan="1" colspan="1">Ching</th><th align="left" valign="middle" rowspan="1" colspan="1">JoCo</th><th align="left" valign="middle" rowspan="1" colspan="1">MOST</th><th align="left" valign="middle" rowspan="1" colspan="1">OAI</th><th align="left" valign="middle" rowspan="1" colspan="1">SOF</th><th align="left" valign="middle" rowspan="1" colspan="1">RS-I</th><th align="left" valign="middle" rowspan="1" colspan="1">RS-II</th><th align="left" valign="middle" rowspan="1" colspan="1">RS-III</th><th align="left" valign="middle" rowspan="1" colspan="1">Total incl.</th><th align="left" valign="middle" rowspan="1" colspan="1">Total excl.<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hips, n (participants)</td><td align="left" valign="middle" rowspan="1" colspan="1">753 (457)</td><td align="left" valign="middle" rowspan="1" colspan="1">727 (464)</td><td align="left" valign="middle" rowspan="1" colspan="1">614 (442)</td><td align="left" valign="middle" rowspan="1" colspan="1">1776 (1078)</td><td align="left" valign="middle" rowspan="1" colspan="1">4552 (2618)</td><td align="left" valign="middle" rowspan="1" colspan="1">3547 (2399)</td><td align="left" valign="middle" rowspan="1" colspan="1">2460 (1660)</td><td align="left" valign="middle" rowspan="1" colspan="1">1810 (1056)</td><td align="left" valign="middle" rowspan="1" colspan="1">2568 (1463)</td><td align="left" valign="middle" rowspan="1" colspan="1">18,807 (11,637)</td><td align="left" valign="middle" rowspan="1" colspan="1">9708 (6772)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age, mean (sd) years</td><td align="left" valign="middle" rowspan="1" colspan="1">55.65 (5.24)</td><td align="left" valign="middle" rowspan="1" colspan="1">53.09 (5.59)</td><td align="left" valign="middle" rowspan="1" colspan="1">58.21 (8.49)</td><td align="left" valign="middle" rowspan="1" colspan="1">60.84 (7.43)</td><td align="left" valign="middle" rowspan="1" colspan="1">59.96 (8.90)</td><td align="left" valign="middle" rowspan="1" colspan="1">70.07 (4.27)</td><td align="left" valign="middle" rowspan="1" colspan="1">64.84 (6.46)</td><td align="left" valign="middle" rowspan="1" colspan="1">62.75 (6.15)</td><td align="left" valign="middle" rowspan="1" colspan="1">56.13 (4.85)</td><td align="left" valign="middle" rowspan="1" colspan="1">61.84 (8.32)</td><td align="left" valign="middle" rowspan="1" colspan="1">64.56 (8.49)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BMI, mean (sd) kg/m2</td><td align="left" valign="middle" rowspan="1" colspan="1">26.11 (4.02)</td><td align="left" valign="middle" rowspan="1" colspan="1">25.44 (4.09)</td><td align="left" valign="middle" rowspan="1" colspan="1">29.62 (6.01)</td><td align="left" valign="middle" rowspan="1" colspan="1">29.60 (5.03)</td><td align="left" valign="middle" rowspan="1" colspan="1">28.12 (4.60)</td><td align="left" valign="middle" rowspan="1" colspan="1">26.42 (4.37)</td><td align="left" valign="middle" rowspan="1" colspan="1">26.37 (3.53)</td><td align="left" valign="middle" rowspan="1" colspan="1">27.20 (3.86)</td><td align="left" valign="middle" rowspan="1" colspan="1">27.46 (4.08)</td><td align="left" valign="middle" rowspan="1" colspan="1">27.40 (4.49)</td><td align="left" valign="middle" rowspan="1" colspan="1">27.59 (4.73)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Men, n (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">117 (15.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">0(0)</td><td align="left" valign="middle" rowspan="1" colspan="1">298 (48.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">501 (28.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">1895 (41.6)</td><td align="left" valign="middle" rowspan="1" colspan="1">0 (0.0)</td><td align="left" valign="middle" rowspan="1" colspan="1">955 (38.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">756 (41.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">1109 (43.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">5631 (29.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">3158 (32.5)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">WCEA &#x02264;20&#x000b0;, n (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">48 (6.4)</td><td align="left" valign="middle" rowspan="1" colspan="1">43 (5.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">18 (2.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">274 (15.4)</td><td align="left" valign="middle" rowspan="1" colspan="1">234 (5.1)</td><td align="left" valign="middle" rowspan="1" colspan="1">106 (3.0)</td><td align="left" valign="middle" rowspan="1" colspan="1">161 (6.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">106 (5.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">174 (6.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">1164 (6.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">510 (5.3)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">WCEA &#x02264;25&#x000b0;, n (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">218 (29.07)</td><td align="left" valign="middle" rowspan="1" colspan="1">173 (23.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">130 (21.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">795 (44.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">1085 (23.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">575 (16.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">628 (25.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">453 (25.0)</td><td align="left" valign="middle" rowspan="1" colspan="1">709 (27.6)</td><td align="left" valign="middle" rowspan="1" colspan="1">4766 (25.3)</td><td align="left" valign="middle" rowspan="1" colspan="1">2105 (21.7)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ADR &#x02264;250, n (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">248 (32.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">212 (29.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">159 (25.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">715 (40.3)</td><td align="left" valign="middle" rowspan="1" colspan="1">1273 (28.0)</td><td align="left" valign="middle" rowspan="1" colspan="1">955 (26.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">857 (34.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">651 (36.0)</td><td align="left" valign="middle" rowspan="1" colspan="1">847 (33.0)</td><td align="left" valign="middle" rowspan="1" colspan="1">5917 (31.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">2694 (27.8)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">mAI &#x02265; 13&#x000b0;, n (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">14 (1.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">26 (3.6)</td><td align="left" valign="middle" rowspan="1" colspan="1">11 (1.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">72 (4.1)</td><td align="left" valign="middle" rowspan="1" colspan="1">84 (1.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">54 (1.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">50 (2.0)</td><td align="left" valign="middle" rowspan="1" colspan="1">35 (1.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">51 (2.0)</td><td align="left" valign="middle" rowspan="1" colspan="1">397 (2.1)</td><td align="left" valign="middle" rowspan="1" colspan="1">191 (2.0)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">OA score=2 follow-up, men/women (%/%)</td><td align="left" valign="middle" rowspan="1" colspan="1">101 (13.4)</td><td align="left" valign="middle" rowspan="1" colspan="1">61 (8.4)</td><td align="left" valign="middle" rowspan="1" colspan="1">39 (6.4)</td><td align="left" valign="middle" rowspan="1" colspan="1">10 (0.6)</td><td align="left" valign="middle" rowspan="1" colspan="1">21 (0.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">60 (1.7)</td><td align="left" valign="middle" rowspan="1" colspan="1">22 (0.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">7 (0.4)</td><td align="left" valign="middle" rowspan="1" colspan="1">57 (2.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">77/301 (1.4/2.3)</td><td align="left" valign="middle" rowspan="1" colspan="1">2390 (24.6)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P67">CHECK= Cohort Hip and Cohort Knee, MOST= Multi-center Osteoarthritis Study, OAI= Osteo Arthritis Initiative, RS-I= Rotterdam Study-I, RS-II=Rotterdam Study-II, RS-III= Rotterdam Study-III (RS-III), Ching= the Chingford Study, JoCo=The Johnston County Project, SOF= Study of Osteoporotic Fractures, WCEA= Wiberg Center Edge Angle, ADR= Acetabular Depth-Width Ratio, mAI= Modified Acetabular Index. OA score: 0= no RHOA, 1= Doubtful RHOA, 2= Definite RHOA.</p></fn><fn id="TFN2"><label>a</label><p id="P68">Excluded hips are defined as all eligible hips for analysis but with OA score 1 or 2 at baseline.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2" orientation="landscape"><label>Table II</label><caption><p id="P69">Associations between various radiographic definitions of AD and incident RHOA.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Definition of AD</th><th align="left" valign="top" rowspan="1" colspan="1">Hips with AD at baseline, n</th><th align="left" valign="top" rowspan="1" colspan="1">Hips with incident RHOA at follow-up, n</th><th align="left" valign="top" rowspan="1" colspan="1">Absolute risk (%)</th><th align="left" valign="top" rowspan="1" colspan="1">Unadjusted OR (95% CI)<sup><xref rid="TFN5" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">Adjusted OR (95% CI)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">WCEA &#x02264;25&#x000b0;</td><td align="left" valign="top" rowspan="1" colspan="1">4766</td><td align="left" valign="top" rowspan="1" colspan="1">127</td><td align="left" valign="top" rowspan="1" colspan="1">127/4766 (2.7)</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>1.73 (1.33&#x02013;2.25)</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>1.80 (1.40&#x02013;2.34)</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">WCEA &#x02264;20&#x000b0;</td><td align="left" valign="top" rowspan="1" colspan="1">1164</td><td align="left" valign="top" rowspan="1" colspan="1">34</td><td align="left" valign="top" rowspan="1" colspan="1">34/1164 (2.9)</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>1.80 (1.28&#x02013;2.52)</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>1.96 (1.26&#x02013;3.02)</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ADR &#x02264;250</td><td align="left" valign="top" rowspan="1" colspan="1">5917</td><td align="left" valign="top" rowspan="1" colspan="1">144</td><td align="left" valign="top" rowspan="1" colspan="1">144/5917 (2.4)</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>1.48 (1.15&#x02013;1.90)</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>1.53 (1.19&#x02013;1.96)</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">mAI &#x02265; 13&#x000b0;</td><td align="left" valign="top" rowspan="1" colspan="1">397</td><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">14/397 (3.5)</td><td align="left" valign="top" rowspan="1" colspan="1">-<sup><xref rid="TFN6" ref-type="table-fn">b</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">-<sup><xref rid="TFN6" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">WCEA &#x02264;25&#x000b0; &#x00026; ADR &#x02264;250 &#x00026; mAI &#x02265; 13&#x000b0;<sup><xref rid="TFN7" ref-type="table-fn">c</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">351</td><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">14/351 (4.0)</td><td align="left" valign="top" rowspan="1" colspan="1">-<sup><xref rid="TFN6" ref-type="table-fn">b</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">-<sup><xref rid="TFN6" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">WCEA &#x02264;25&#x000b0; or ADR &#x02264;250 or mAI &#x02265; 13&#x000b0;<sup><xref rid="TFN8" ref-type="table-fn">d</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">7480</td><td align="left" valign="top" rowspan="1" colspan="1">176</td><td align="left" valign="top" rowspan="1" colspan="1">176/7480 (2.4)</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>1.47 (1.16&#x02013;1.88)</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>1.52 (1.19&#x02013;1.94)</bold>
</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p id="P70">ORs were adjusted for age, BMI, biological sex, and hip side, and were accounted for by clustering cohort and individual. WCEA: Wiberg center edge angle. ADR: acetabular depth-width ratio. mAI: modified acetabular index. OR: odds ratio. CI: confidence interval.</p></fn><fn id="TFN4"><p id="P71">Significant associations are printed in <bold>bold</bold>.</p></fn><fn id="TFN5"><label>a</label><p id="P72">The unadjusted odds ratios are calculated using the logistic regression model with generalized mixed effects with 3 levels (cohort, person and -hip side correlation) unadjusted for age, biological sex, and BMI.</p></fn><fn id="TFN6"><label>b</label><p id="P73">Too few cases with both predictor and outcome to calculate an OR.</p></fn><fn id="TFN7"><label>c</label><p id="P74">The reference group contained hips free of AD and hips with only 1 or 2 measures of AD.</p></fn><fn id="TFN8"><label>d</label><p id="P75">The reference group contained hips free of any measure to define AD.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3" orientation="landscape"><label>Table III</label><caption><p id="P76">Absolute and relative risk of hips with acetabular dysplasia (WCEA &#x02264;25&#x000b0;) to develop incident radiographic hip osteoarthritis stratified by age group, BMI, and biological sex.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Strata</th><th align="left" valign="top" rowspan="1" colspan="1">Total hips in group, n</th><th align="left" valign="top" rowspan="1" colspan="1">Hips with AD (WCEA &#x02264;25&#x000b0;), n</th><th align="left" valign="top" rowspan="1" colspan="1">Hips with incident RHOA, n</th><th align="left" valign="top" rowspan="1" colspan="1">Hips with AD and incident RHOA, n</th><th align="left" valign="top" rowspan="1" colspan="1">Absolute Risk, %<sup><xref rid="TFN9" ref-type="table-fn">a</xref></sup></th><th align="left" valign="top" rowspan="1" colspan="1">Relative Risk, % (95% CI)<sup><xref rid="TFN10" ref-type="table-fn">b</xref></sup></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Age group (years)</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">40&#x02013;50</td><td align="left" valign="top" rowspan="1" colspan="1">1753</td><td align="left" valign="top" rowspan="1" colspan="1">526 (30.0)</td><td align="left" valign="top" rowspan="1" colspan="1">35 (2.0)</td><td align="left" valign="top" rowspan="1" colspan="1">11</td><td align="left" valign="top" rowspan="1" colspan="1">0.6</td><td align="left" valign="top" rowspan="1" colspan="1">1.07 (0.53&#x02013;2.17)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">51&#x02013;60</td><td align="left" valign="top" rowspan="1" colspan="1">6738</td><td align="left" valign="top" rowspan="1" colspan="1">1921 (28.5)</td><td align="left" valign="top" rowspan="1" colspan="1">159 (2.4)</td><td align="left" valign="top" rowspan="1" colspan="1">57</td><td align="left" valign="top" rowspan="1" colspan="1">0.8</td><td align="left" valign="top" rowspan="1" colspan="1">1.40 (1.02&#x02013;1.93)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">61&#x02013;70</td><td align="left" valign="top" rowspan="1" colspan="1">7192</td><td align="left" valign="top" rowspan="1" colspan="1">1691 (23.5)</td><td align="left" valign="top" rowspan="1" colspan="1">128 (1.8)</td><td align="left" valign="top" rowspan="1" colspan="1">44</td><td align="left" valign="top" rowspan="1" colspan="1">0.6</td><td align="left" valign="top" rowspan="1" colspan="1">1.70 (1.19&#x02013;2.44)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">70+</td><td align="left" valign="top" rowspan="1" colspan="1">3124</td><td align="left" valign="top" rowspan="1" colspan="1">628 (20.1)</td><td align="left" valign="top" rowspan="1" colspan="1">56 (1.8)</td><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">0.5</td><td align="left" valign="top" rowspan="1" colspan="1">1.45 (0.81&#x02013;2.61)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>BMI</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c; 25</td><td align="left" valign="top" rowspan="1" colspan="1">5874</td><td align="left" valign="top" rowspan="1" colspan="1">1380 (23.5)</td><td align="left" valign="top" rowspan="1" colspan="1">142 (2.4)</td><td align="left" valign="top" rowspan="1" colspan="1">48</td><td align="left" valign="top" rowspan="1" colspan="1">0.8</td><td align="left" valign="top" rowspan="1" colspan="1">1.66 (1.18&#x02013;2.34)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02265;25</td><td align="left" valign="top" rowspan="1" colspan="1">12,933</td><td align="left" valign="top" rowspan="1" colspan="1">3386 (26.2)</td><td align="left" valign="top" rowspan="1" colspan="1">236 (1.8)</td><td align="left" valign="top" rowspan="1" colspan="1">79</td><td align="left" valign="top" rowspan="1" colspan="1">0.6</td><td align="left" valign="top" rowspan="1" colspan="1">1.42 (1.09&#x02013;1.85)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Biological sex</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Men</td><td align="left" valign="top" rowspan="1" colspan="1">5631</td><td align="left" valign="top" rowspan="1" colspan="1">1369 (24.3)</td><td align="left" valign="top" rowspan="1" colspan="1">77 (1.4)</td><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">0.2</td><td align="left" valign="top" rowspan="1" colspan="1">0.69 (0.39&#x02013;1.23)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Women</td><td align="left" valign="top" rowspan="1" colspan="1">13,176</td><td align="left" valign="top" rowspan="1" colspan="1">3397 (25.8)</td><td align="left" valign="top" rowspan="1" colspan="1">301 (2.3)</td><td align="left" valign="top" rowspan="1" colspan="1">113</td><td align="left" valign="top" rowspan="1" colspan="1">0.9</td><td align="left" valign="top" rowspan="1" colspan="1">1.73 (1.37&#x02013;2.18)</td></tr></tbody></table><table-wrap-foot><fn id="TFN9"><label>a</label><p id="P77">The absolute risk was calculated using the following equation: (number of hips with pincer morphology and RHOA/Total number of hips in subgroup).</p></fn><fn id="TFN10"><label>b</label><p id="P78">The relative risk was calculated using the following equation: (number of hips with pincer &#x00026; RHOA/(number of hips with pincer &#x00026; RHOA + number of hips with pincer only)) / (number of hips with RHOA without pincer morphology/ (number of hips with RHOA without pincer morphology + number of hips without pincer morphology or RHOA)).</p></fn></table-wrap-foot></table-wrap></floats-group></article>